Owner MediGene AG

Inventors Perabo, Luca; Buning, Hildegard; Enssle, Jorg; Ried, Martin; Hallek, Michael; Huttner, Nadja

Agent Watermark

Pub. Number AU-B-2008202032

Parent 2002352261

Filing date 7 May 2008

Wipo publication date 26 November 2009

Acceptance publication date 20 September 2012

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 Medicinal preparations containing peptides

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

C07K 14/01 Peptides having more than 20 amino acids

C07K 14/015 Peptides having more than 20 amino acids

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/33 Mutation or genetic engineering - Genes encoding viral proteins

C12N 15/35 Mutation or genetic engineering

C12N 15/64 Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

C12N 15/864 Mutation or genetic engineering - Parvoviral vectors

C12Q 1/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids